Detection of Helicobacter Pylori Infection in Patients with Gastrointestinal Diseases

dc.contributor.authorWarkaa Mohammed Khadim
dc.contributor.authorKhairi Jameel Al-Ruaby
dc.contributor.authorAlaa Ali Matrood
dc.date.accessioned2026-01-02T11:32:26Z
dc.date.issued2022-10-18
dc.description.abstractHelicobacter pylori (H. pylori) represent one of the most prevalent pathogens in humans, which affecting more than half of the population. Infected people usually remain a symptomatic, but, approximately 30% of individuals may develop gastro-duodenal disease with symptoms such as gastritis (chronic active gastritis, and atrophic gastritis), peptic ulcer, gastric cancer and mucosa associated lymphoid tissue lymphoma (MALT).
dc.formatapplication/pdf
dc.identifier.urihttps://geniusjournals.org/index.php/emrp/article/view/2368
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/77387
dc.language.isoeng
dc.publisherGenius Journals
dc.relationhttps://geniusjournals.org/index.php/emrp/article/view/2368/2038
dc.sourceEurasian Medical Research Periodical; Vol. 13 (2022): EMRP; 106-113
dc.source2795-7624
dc.subjectHelicobacter pylori
dc.subjectgastrointestinal symptoms
dc.subjectNon-invasive tests
dc.subjectgastrointestinal disease
dc.titleDetection of Helicobacter Pylori Infection in Patients with Gastrointestinal Diseases
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
khadim_2022_detection_of_helicobacter_pylori_infecti.pdf
item.page.filesection.size
493.49 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections